Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression. May 1, 2015
Ketamine-induced modulation of the thalamo-cortical network in healthy volunteers as a model for schizophrenia April 20, 2015
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review April 13, 2015
Ketamine as a promising prototype for a new generation of rapid-acting antidepressants February 27, 2015
Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder February 17, 2015
